Report: Merck invested in Moderna at $18B valuation
August 17, 2018 at 05:30 AM EDT
According to newly-released data from PitchBook, Merck bought into the biotech at an $18 billion valuation in May — just a few months after Moderna raised money at a $7 billion valuation.
